Our latest publication is out: Identifying and Managing Seizures in Autism
Recent Posts
- TA Clinical & Research newsletter for professionals – Issue 2 out!
- Century-old drug offers new hope for autism treatment
- Autism charity calls for better medical care for people “left in pain or to die prematurely”
- Our latest publication is out: Identifying and Managing Seizures in Autism
- Treating Autism coming to Basildon, ESSEX
Recent Comments
- Please share- ASD children who make progress on Parents’ stories
Archives
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- May 2016
- April 2016
- March 2016
- October 2015
- June 2015
- November 2014
- September 2014
- June 2014
- January 2014
- June 2013
- March 2013
- March 2012
- January 2012
- November 2011
- October 2011
- September 2011
- June 2011
- May 2011
- March 2011
- September 2010
Up to 40% of all individuals with autism develop epilepsy at some point in their lives.
Epilepsy is the leading cause of premature death in autism.
Even in the absence of a clinical seizure disorder, a large majority – up to 80% – of children and adults with autism suffer abnormal subclinical epileptiform activity in their brains. Those abnormalities are not visible to the eye, but can only be detected by a prolonged overnight EEG, or ideally an MEG investigation.
Treatments aimed at control of seizure activity sometimes lead to reduction of autistic features.
Our latest publication is out! Please feel free to read, download, and share.
Free printed copies are available for distribution, email us at
Posted by TA team on Wednesday, March 22nd, 2017 @ 5:33PM
Categories: News